Overview Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain Status: RECRUITING Trial end date: 2026-08-01 Target enrollment: Participant gender: Summary A randomized study to determine safety and efficacy of single subcutaneous (SC) administration of HAL treatment in patients with CINP.Phase: PHASE2 Details Lead Sponsor: Dogwood Therapeutics Inc.